GlassScriptPhysician profile
Stephen G Weiss
NPI 1073564910
$9,480.39
in general payments reported to CMS, 2019-2025
54 companies · $2,906 in 2025
The $2,906 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,280 · 2020: $548 · 2021: $789 · 2022: $808 · 2023: $1,483 · 2024: $1,666 · 2025: $2,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,329 · Travel and Lodging: $489 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,328.87 |
| Travel and Lodging | $489.38 |
| Education | $237.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,278.55 | 2022-2025 | Interstim, Altaviva |
| Astellas Pharma US INC | $953.06 | 2019-2025 | Xtandi |
| Myriad Genetic Laboratories, INC. | $803.10 | 2021-2025 | Prolaris |
| Janssen Biotech, INC. | $656.00 | 2019-2025 | Erleada, Akeega |
| Ferring Pharmaceuticals INC. | $555.34 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $425.83 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $398.68 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $379.35 | 2019-2023 | Xiaflex, Aveed |
| Pfizer INC. | $367.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $332.72 | 2022-2025 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $277.21 | 2022-2025 | |
| Tempus Ai, INC | $273.60 | 2024-2025 | Xt Cdx |
| Sumitomo Pharma America, INC. | $174.68 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $165.88 | 2019-2025 | Lithovue |
| Endo USA, INC. | $151.56 | 2024-2025 | Xiaflex, Aveed |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $150.59 | 2022-2025 | Botox |
| Allergan, INC. | $147.08 | 2019-2021 | |
| Amgen INC. | $143.62 | 2019-2020 | |
| Urogen Pharma, INC. | $140.05 | 2020-2025 | |
| Tolmar Pharmaceuticals, INC. | $134.68 | 2019-2022 | |
| Antares Pharma, INC. | $125.86 | 2021-2022 | |
| Cook Medical LLC | $119.69 | 2019-2020 | |
| Teleflex LLC | $117.85 | 2021-2025 | Barrigel, Urolift |
| Axonics, INC. | $107.83 | 2020-2024 | Axonics |
| Blue Earth Diagnostics | $96.46 | 2023 | |
| Accord Healthcare, INC. | $91.14 | 2022-2025 | |
| Tolmar, INC. | $82.51 | 2025 | Eligard, Jatenzo |
| Seagen INC. | $80.00 | 2025 | |
| Myovant Sciences INC. | $78.11 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $76.76 | 2022-2023 | Erleada |
| Duchesnay USA Incorporated | $64.98 | 2019 | |
| Procept Biorobotics Corporation | $64.33 | 2025 | |
| Olympus America INC. | $45.90 | 2023-2025 | Itind System |
| Alnylam Pharmaceuticals INC. | $45.22 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $43.73 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $40.77 | 2020 | |
| Smith+Nephew, INC. | $36.57 | 2023-2025 | Stravix Pl, Grafix Pl |
| Lsi Solutions INC | $23.72 | 2024 | Ti-Knot, Jnw Urtrac, Running Device |
| Genzyme Corporation | $23.61 | 2020 | |
| Foundation Medicine, INC. | $22.88 | 2023 | |
| Hollister Incorporated | $19.33 | 2023 | Onli, Infyna Chic, Vapro Pocket |
| Immunitybio, INC. | $18.14 | 2025 | |
| Laborie Medical Technologies Corp. | $17.96 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Agiliti Surgical, INC. | $17.21 | 2024 | Shockpulse For Pcnl Support, Koelis Trinity Fusion Biopsy System |
| Verity Pharmaceuticals INC. | $16.70 | 2022 | |
| Medtronic USA, INC. | $15.59 | 2020 | |
| Ethicon US, LLC | $15.30 | 2021 | |
| Clarus Therapeutics INC. | $15.22 | 2021 | |
| Neotract INC. | $13.91 | 2019 | |
| Mindray Ds USA, INC. | $13.21 | 2023 | A7 Anesthesia System |
| Dentsply Ih INC. | $10.99 | 2019 | |
| Ambu INC. | $9.57 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.